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Abstract
Background. Proliferative glomerulonephritides are
characterized by the influx of leucocytes. Heparan
sulfate (HS) plays an important role in the recruitment,
rolling and firm adhesion of leucocytes to activated
endothelium. Recently, we have shown the importance
of HS on activated mouse glomerular endothelial
cells (mGEnC-1) for the firm adhesion of leucocytes
in a static adhesion assay.
In the present study, we evaluated the role of HS on
glomerular endothelial cells and the effect of adding
heparinoids on the leucocyte–glomerular endothelium
interaction under dynamic flow conditions.
Methods. The number of rolling and firmly adhering
leucocytes, and the rolling velocity of leucocytes was
determined on a monolayer of unactivated or TNF-
a-activated mGEnC-1 under dynamic flow conditions
using physiological relevant shear stress rates in a flow
chamber system. Furthermore, the effects of removal
of HS on TNF-a-activated mGEnC-1 by heparinase
III treatment, and of different concentrations of
heparin, tinzaparin and HS, on the rolling and
adhesion of leucocytes were evaluated.
Results. At the calculated physiological shear stress
rate of 0.8 dynes/cm2 the number of rolling and firmly
adhering leucocytes to mGEnC-1 increased 2-fold after
activation with TNF-a, whereas the rolling velocity of
the leucocytes decreased 2-fold. Addition of heparin,
tinzaparin or HS, and the removal of HS on mGEnC-1
reduced the number of leucocytes rolling and adhering
to activated mGEnC-1 about 2–3-fold, while the
rolling velocity increased more than 2-fold.
Conclusions. HS on activated glomerular endothelial
cells is important for the interaction with leucocytes
under flow conditions, while exogenous heparinoids
interfere with this interaction. These results suggest
that supplementary treatment of proliferative
glomerulonephritides with heparinoids is an interesting
option to pursue.
Keywords: adhesion of leucocytes; glomerular
endothelial cells; glomerulonephritis; heparin; low
molecular weight heparin; rolling of leucocytes
Introduction
Inflammatory lesions are manifested in a range of
glomerular diseases and are characterized by the influx
of leucocytes. The endothelial trafficking of leucocytes
occurs in a sequential four-step process, i.e. tethering
to, rolling over, firm adhesion to, and transmigration
through the activated endothelium [1] (Figure 1). In all
these steps, heparan sulfate (HS) plays an important
role by binding chemokines, cytokines, selectins,
integrins and adhesion molecules [2]. HS belongs to
the family of strong negatively charged glycosamino-
glycans that also includes heparin, which contains
more sulfate groups and iduronic acid residues than
HS (Figure 2).
The adherence of leucocytes to the vessel wall
depends on the strength of the interaction between
leucocytes and the endothelium, which is determined
by receptor–ligand interactions and affected by shear
forces imposed by the fluid flow in the circulation.
Wall shear stress plays a role in maintaining vascular
haemodynamics and haemostasis, and also affects
heparan sulfate proteoglycan synthesis and fine struc-
ture [3]. An increased synthesis of glycosaminoglycan
has been observed for endothelial cells that were
subjected to a shear stress rate of 15–40 dynes/cm2
for 24 h [4], while an inhibition of glycosaminoglycan
synthesis has been observed for endothelial cells that
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were subjected to a shear stress rate of 1 dyne/cm2 for
2 h [5]. Furthermore, endothelial HS participates in
mechanosensing that mediates nitric oxide production
in response to shear stress [6], while vascular smooth
muscle cell HS promotes contractile responses to
increases in shear stress [7]. The concerted action of
adhesion molecules, chemokines and endothelial HS
during inflammation is dependent on the shear stress in
a specific microvascular bed. The in vivo conditions
of dynamic blood flow can be mimicked in vitro by
flow chambers (Figure 3), which are frequently used to
evaluate the rolling and firm adhesion of leucocytes
to cultured endothelium [8]. In a flow chamber the
shear stress rate () (in dynes/cm2) can be calculated
by the Navier–Stokes equation and set by adjusting the
volumetric flow rate (Figure 3).
Recently, we have shown the importance of HS
on activated mouse glomerular endothelial cells
(mGEnC-1) [9] for the firm adhesion of leucocytes by
using an in vitro static adhesion assay (A. Rops et al.,
unpublished data). Heparin and low molecular weight
heparin are frequently clinically applied as anti-
coagulants, but could also be considered for supple-
mentary treatment of glomerulonephritis by interfering
with the interaction between leucocytes and glomerular
endothelium. Currently, there are no data on whether
the HS on activated glomerular endothelium plays a
role in the interaction of leucocytes under dynamic
flow conditions. Furthermore, it is not known whether
heparinoids are able to interfere with the interaction of
leucocytes with the activated glomerular endothelium
under dynamic flow conditions. Therefore, we evalu-
ated in vitro the number of rolling and firmly adhering
leucocytes and the rolling velocity of leucocytes on
glomerular endothelial cells under dynamic flow
conditions after removal of HS on glomerular
endothelial cells and in the presence or absence of
heparin, tinzaparin or HS.
Subjects and methods
Cell cultures
The conditionally immortalizedmouse glomerular endothelial
cell line (mGEnC-1) with all features of primary glomerular
endothelial cells was cultured as described [9]. The mGEnC-1
was grown on coverslips (40mm) (Bioptechs, Inc., Butler, PA,
USA) pre-coated with 1% gelatin and fibronectin (1 mg/cm2)
(Sigma-Aldrich Chemie BV, Zwijndrecht, the Netherlands) in
normal growth medium at 378C, until they were 100%
confluent. Where indicated, cells were activated by incubation
with TNF-a (10 ng/ml; Peprotech, Rocky Hill, NJ, USA) for
18 h. The murine granulocyte cell line 32Dcl3 [10,11], which
lacks cell surface HS [12], but highly expresses L-selectin,
Mac-1 and the granulocyte marker (NIMP-R14) [13], was
maintained in RPMI-1640 (Invitrogen Life Technologies,
Breda, the Netherlands), supplemented with 10%WEHI-3B-
conditioned medium as a source of murine interleukin-3
(DSMZ, Braunschweig, Germany), 1% pyruvate, 1% gluta-
max, 10% foetal calf serum and 1% penicillin/streptomycin
(Invitrogen Life Technologies).
Removal of endothelial heparan sulfate
HS on TNF-a-activated mGEnC-1 was removed by treat-
ment with 0.25U/ml heparinase III (Sigma-Aldrich,
Zwijndrecht, the Netherlands) in cell culture medium
(pH 7.5) for 1 h at 378C. The terminal 4,5-unsaturated
uronate residues that arise after heparinase III treatment
are recognized by antibody 3G10 [14], which was used to
evaluate enzyme activity.
Adhesion experiments under flow conditions
Adhesion of 32Dcl3 granulocyte cells to mGEnC-1 was
measured under flow conditions in a parallel plate Focht
flow perfusion chamber with well-defined characteristics,
essentially as depicted in Figure 3. A coverslip with a
monolayer of mGEnC-1 was assembled in the flow chamber,
which was mounted on an inverted phase-contrast micro-
scope stage (Axiovert 35M, Zeiss, Germany) that was
connected to a camera (VarioCam, PCO computer Optics
GmbH, Kelheim, Germany) and controlled by a computer.
The x, y and z positions of the microscope table were
regulated by a computer-driven x, y, z stage controller. Then,
32Dcl3 granulocyte cells were resuspended in plain
Fig. 1. The sequential steps of leucocyte trafficking on the activated
endothelium. Circulating leucocytes are tethered to the activated
endothelium. Subsequently, leucocytes are slowing down by
rolling over the activated endothelium, which is facilitated by
interaction of selectins and selectin ligands. During this process
locally produced chemokines/cytokines bound to endothelial HS
further activate integrin on leucocytes leading to stronger leucocyte–
endothelium interactions. Thereafter, firmer adhesion of leucocytes
to the activated endothelium takes place, which is mediated
by integrins and integrin ligands. Finally, leucocytes transmigrate/
cross the endothelial monolayer. Notably, in all steps in
leucocyte trafficking over activated endothelium heparan sulfate is
involved [26,27].
Fig. 2. Structural features of heparin/heparan sulfate. The possible
modifications, i.e. N-deacetylation and N-sulfation of N-acetyl-
glucosamine, C-5 epimerization of glucuronate to iduronate and
O-sulfation at various positions (C-2, C-3 and C-6), are indicated in
bold. Heparin contains a higher iduronate/glucuronate ratio and
a higher percentage of sulfated domains than heparan sulfate.
Represented by n are 50–150 disaccharide units of glucosamine and
uronic acid.
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DMEM-HAM F12 medium (Invitrogen Life Technologies)
at a concentration of 0.5 106 cells/ml and pre-warmed to
378C. The 32Dcl3 granulocyte cells were aspirated from a
reservoir through the perfusion chamber with a withdrawal
syringe pump (Harvard apparatus, Holliston, MA, USA;
ANTEC, Leiden, The Netherlands). The complete system
was present in a 378C incubator. Temperature fine-tuning
was performed by the Bioptechs FCS2 controller.
The experiment started with a continuous flow of plain
DMEM-HAM F12 medium of 378C for 2min over the
monolayer of mGEnC-1. Subsequently, 32Dcl3 granulocyte
cells were perfused for 60 s at shear stress rates in
the physiological range of 0.4–1.6 dynes/cm2, i.e. with a
volumetric flow rate Q of 1.2–4.7 ml/s, respectively. Video
recordings of one microscopic field (0.14mm2) were read
continuously (1 image/s) and analysed afterwards with an
in-house developed software program [15]. Individual 32Dcl3
granulocyte cells received a unique ID and could be tracked
and analysed in time, which allowed the determination
of the average number of rolling (defined at a movement of
4–100 mm/s) and firmly adhering (defined at a movement
of 0–4 mm/s) cells, as well as the average rolling velocity.
The effect of 10, 50 or 250mg/ml heparin (Sigma-Aldrich),
tinzaparin (Innohep) (Brocacef Holding NV, Maarssen,
the Netherlands) or HS from bovine kidney (Seikagaku,
Tokyo, Japan) [16] on the average number of rolling and
firmly adhering 32Dcl3 granulocyte cells, and on the average
velocity of rolling 32Dcl3 granulocyte cells was evaluated
on TNF-a-activated mGEnC-1 at a shear stress rate of
0.8 dynes/cm2 for 60 s with a recording of 10 images/s.
All perfusions were performed in triplicate on at least three
separate experiments.
Statistical analysis
All values are expressed as means SEM and significance
was determined by Mann–Whitney U-testing using
Fig. 3. In vitro dynamic flow chamber system. The shear stress rate () expressed in dynes/cm2 in the flow chamber can be calculated and set
according to the Navier–Stokes equation, ¼ (6Qm)/(wh2), in which Q is the volumetric flow rate, m is the viscosity of the fluid (in mPa s), w is
the slide width and h is the height of the flow chamber, respectively.
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GraphPad Prism, version 4.0 software (GraphPad Software,
Inc., San Diego, CA).
Results
Rolling and adhesion of granulocytes to unstimulated
and TNF-a-activated mouse glomerular endothelial
cells at different shear stress rates
We calculated an approximate shear stress rate in
mouse glomerular capillaries of about 0.8 dynes/cm2
using Hagen–Poiseuille’s law. However, the actual
value of the shear stress rate in glomerular capillaries
may be different from 0.8 dynes/cm2, since Hagen–
Poiseuille’s law is only suitable for Newtonian fluids,
while in addition the viscosity and volumetric flow rate
of the blood in the glomerular capillaries, and the
diameter of the glomerular capillaries may dynamically
change. Therefore, we evaluated the number of rolling
and firmly adhering 32Dcl3 granulocyte cells on both
unstimulated and TNF-a-activated mGEnC-1 at shear
stress rates of 0.4, 0.8 and 1.6 dynes/cm2, respectively.
In addition, the average rolling velocity of 32Dcl3
granulocyte cells at different shear stress rates was
determined. It appeared that at a shear stress rate of
0.4 dynes/cm2, the results were not discriminating,
since the numbers of rolling and firmly adhering
32Dcl3 granulocyte cells, and the average rolling
velocity of 32Dcl3 granulocyte cells were not signifi-
cantly different between unstimulated mGEnC-1
and TNF-a-activated mGEnC-1 (data not shown).
In contrast, at a shear stress rate of 0.8 dynes/cm2
the numbers of rolling and firmly adhering 32Dcl3
granulocyte cells to mGEnC-1 increased about 2-fold
after activation with TNF-a (Figure 4A and B), while
the average rolling velocity decreased about 2-fold
(Figure 4C). At a shear stress rate of 1.6 dynes/cm2 the
numbers of rolling and firmly adhering 32Dcl3
granulocyte cells, and the average rolling velocity
were already reduced several folds on unactivated
mGEnC-1 when compared to the shear stress rate of
0.8 dynes/cm2 (Figure 4A and B). However, despite
these lower numbers, also at a shear stress rate of
1.6 dynes/cm2 the numbers of rolling and firmly
adhering 32Dcl3 granulocyte cells to mGEnC-1
significantly increased after activation with TNF-a
(Figure 4A and B). In contrast to the shear stress
rate of 0.8 dynes/cm2, the average rolling velocity
of 32Dcl3 granulocyte cells at a shear stress rate
of 1.6 dynes/cm2 was not significantly affected by
activation of mGEnC-1 (Figure 4C). These
results indicate that both rolling and firm adhesion
of 32Dcl3 granulocyte cells as well as the average
rolling velocity are affected by the activation status
of mGEnC-1 and by different shear stress rates.
Since the calculated shear stress rate in glomerular
capillaries is 0.8 dynes/cm2, this shear stress is the most
suitable rate to test leucocyte trafficking in our in vitro
flow system.
Removal of HS on TNF-a-activated mouse glomerular
endothelial cells and the addition of heparin, tinzaparin
or HS interfere with the rolling and adhesion of 32Dcl3
granulocyte cells
Previously, we showed that heparin, the low molecular
weight heparin tinzaparin and HS reduced the firm
adhesion of 32Dcl3 granulocyte cells to TNF-
a-activated mGEnC-1 under static conditions in an
in vitro adhesion assay (Table 1; A. Rops et al.,
unpublished data). Here, we evaluated the effect of
removal of HS on TNF-a-activated mGEnC-1 by
heparinase III treatment, and the addition of heparin,
tinzaparin and HS on the number of rolling and
firmly adhering 32Dcl3 granulocyte cells, and on
the rolling velocity of 32Dcl3 granulocyte cells
Fig. 4. Rolling and adhesion of 32Dcl3 granulocyte cells on
unstimulated and TNF-a-activated mouse glomerular endothelial
cells at different shear stress rates. A monolayer of mGEnC-1 was
either unstimulated or stimulated with TNF-a for 18 h. Then, 32Dcl3
granulocyte cells were perfused at shear stress rates of 0.8 or 1.6
dynes/cm2. The average number SEM of rolling cells (A), the
average number SEM of firmly adhering cells (B) and the
average SEM rolling velocity (C) is shown from three independent
experiments. *P< 0.05 compared with unstimulated mGEnC-1.
Heparinoids interfere with leucocyte trafficking on glomerular endothelium 1073
 at K
atholieke U
niversiteit on July 9, 2012
http://ndt.oxfordjournals.org/
D
ow
nloaded from
 
on activated mGEnC-1 cells at the shear stress rate of
0.8 dynes/cm2. It appeared that removal of HS on
mGEnC-1 and the addition of 250 mg/ml heparin,
tinzaparin or HS significantly reduced about 2–4-fold
the number of rolling and firmly adhering 32Dcl3
granulocyte cells on TNF-a-activated mGEnC-1
(Figure 5A and B), while the rolling velocity of
32Dcl3 granulocyte cells increased more than 2-fold
(Figure 5C). We also tested the effect of two lower
concentrations of heparin and tinzaparin, i.e. 10 and
50 mg/ml. Notably, the concentration of 10 mg/ml
approximates the concentrations that can be found in
the circulation of patients that have received heparin or
tinzaparin intravenously. It appeared that even the
addition of 10 mg/ml heparin (Figure 6A) or tinzaparin
(Figure 6B) reduced the number of rolling 32Dcl3
granulocyte cells, while these effects were even more
pronounced for the number of firmly adhering 32Dcl3
granulocyte cells (Figure 6C and D) and the average
rolling velocity (Figure 6E and F). In summary, our
data show that HS on activated glomerular endothe-
lium is crucial for the interaction with leucocytes
under dynamic flow conditions, while heparin(oids)
interfere with the interaction of leucocytes with
activated glomerular endothelium.
Discussion
In this study, we describe the rolling and adhesion of
leucocytes to unstimulated or TNF-a-activated mouse
glomerular endothelial cells (mGEnC-1) at shear stress
rates that approach the shear stress rate in mouse
glomerular capillaries. Furthermore, we evaluate the
effects of clinically applied heparin, the low molecular
weight heparin tinzaparin and HS, on leucocyte
trafficking using an in vitro flow system.
At the shear stress rates of 0.4 and 1.6 dynes/cm2 no
or minor differences could be observed in the rolling,
adhesion and velocity of 32Dcl3 granulocyte cells on
unactivated mGEnC-1 vs activated mGEnC-1, which
may be explained by too low and too high volumetric
flow rates, respectively. The lower rolling velocity of
32Dcl3 granulocyte cells at 1.6 dynes/cm2 compared
with 0.8 dynes/cm2 may be explained by the fact that
fast rolling cells weakly interacted with activated
mGEnC-1 and lost their interaction at 1.6 dynes/cm2,
while the slowly rolling cells interacted more strongly
with activated mGEnC-1 and resisted the shear stress
rate of 1.6 dynes/cm2, which also has been found by
others [17]. The calculated shear stress rate of about
0.8 dynes/cm2 in glomerular capillaries in vivo appeared
to be the most suitable shear stress rate in our in vitro
flow system. Activation of mGEnC-1 induced signifi-
cantly more rolling and adhesion of 32Dcl3 granulo-
cyte cells, which was accompanied with a reduced
Table 1. Percentage inhibition and the concentrations giving 25%
inhibition of firm adhesion of granulocytes to activated mGEnC-1
by heparin, tinzaparin and heparan sulfate in a static adhesion
system
Heparinoid/GAG
Inhibition of adhesion
at 250mg/ml (%) IC25 (mg/ml)
Heparin 44.7 1.7 18
Tinzaparin (Innohep) 54.1 0.9 11
Heparan sulfate 42.1 0.5 36
The percentage inhibition of adhesion by 250mg/ml heparin,
tinzaparin or heparan sulfate is expressed as the mean SEM of
six experiments. The concentrations giving 25% inhibition (IC25) in
mg/ml are indicated. GAG, glycosaminoglycan.
Fig. 5. Removal of HS on TNF-a-activated mouse glomerular
endothelial cells and the addition of heparin, tinzaparin or HS,
interfere with the rolling and adhesion of 32Dcl3 granulocyte cells.
A monolayer of mGEnC-1 was stimulated with TNF-a for 18 h.
Activated mGEnC-1 was incubated with 32Dcl3 granulocyte cells
without further addition, after removal of HS on mGEnC-1 with
heparinase III, or co-incubated with 250 mg/ml heparin, tinzaparin or
HS. The 32Dcl3 granulocyte cells were perfused at a shear stress rate
of 0.8 dynes/cm2. The average numberSEM of rolling cells (A),
the average number SEM of firmly adhering cells (B) and the
average SEM rolling velocity (C) is shown from three independent
experiments. *P< 0.05 compared with untreated cells. HS, heparan
sulfate.
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average rolling velocity of the 32Dcl3 granulocyte cells.
To our knowledge, our data are the first to show
leucocyte trafficking on a well-defined glomerular
endothelial cell line using an in vitro flow system.
Our data confirm the in vitro results of various other
studies that show differences in the number of rolling
and firmly adhering monocytes, eosinophils, leucocytes
and granulocytes under different shear stress
rates to activated human umbilical vein endothelial
cells (HUVEC) [18,19]. Furthermore, an increased
number of rolling and firmly adhering neutrophils
accompanied with a reduced rolling velocity on
TNF-a-activated endothelium compared to unacti-
vated endothelium in vitro has also been described
for endothelium from other vascular beds [20].
Recently, we have shown that HS on activated
glomerular endothelial cells was crucial for the firm
adhesion of leucocytes using a static adhesion assay.
Furthermore, heparin, HS and low molecular weight
heparin preparations such as tinzaparin reduced the
Fig. 6. Dose-response effect of heparin and tinzaparin on the rolling and adhesion of 32Dcl3 granulocyte cells on TNF-a-activated mouse
glomerular endothelial cells. A monolayer of mGEnC-1 was stimulated with TNF-a for 18 h. Activated mGEnC-1 was incubated with 32Dcl3
granulocyte cells without further addition, or together with 10, 50 or 250 mg/ml heparin or tinzaparin, respectively. The 32Dcl3 granulocyte
cells were perfused at a shear stress rate of 0.8 dynes/cm2. The average number SEM of rolling cells (A and B), the average number SEM
of firmly adhering cells (C and D) and the average SEM rolling velocity (E and F) are shown from three independent experiments.
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firm adhesion of 32Dcl3 granulocyte cells to activated
mGEnC-1 about 2-fold under static conditions
(A. Rops et al., unpublished data). In the current
study, we demonstrated that removal of HS on
activated mGEnC-1 and addition of heparin, tinza-
parin and HS reduced the number of rolling and firmly
adhering 32Dcl3 granulocyte cells several fold, which
was accompanied with an increased rolling velocity.
Rolling of leucocytes is mediated by L-selectin on the
leucocyte and the L-selectin ligand, i.e. 6-O-sulfated
HS, on activated (glomerular) endothelium [2]. Firm
adhesion of leucocytes is mediated by integrins such
as Mac-1 on the leucocyte and the Mac-1 ligand, i.e.
N- and 6-O-sulfated HS, on activated (glomerular)
endothelium [2]. The effects we observed after the
removal of HS on glomerular endothelial cells directly
prove that HS on activated glomerular endothelial cells
is crucial for the rolling, firm adhesion and rolling
velocity of leucocytes, most likely because of the loss of
the L-selectin/Mac-1 HS ligands. Notably, the 32Dcl3
granulocyte cells lack cell surface HS, so we exclusively
could evaluate the role of HS on glomerular endothe-
lial cells in the interaction with leucocytes. The effects
of the addition of heparin, tinzaparin and HS can be
explained by the competitive binding of these com-
pounds to L-selectin and/or Mac-1. Therefore, both
the loss of endothelial HS and the competitive binding
of heparinoids to L-selectin/Mac-1 on leucocytes lead
to interference with the leucocyte–endothelium inter-
action, i.e. a lower number of rolling leucocytes, a
higher rolling velocity of leucocytes and a lower
number of firmly adhering leucocytes. Another possi-
ble explanation is that removal of endothelial HS or
incubation with heparinoids leads to loss of bound
chemokines that activate integrins on leucocytes
required for the firm interaction with endothelial
cells. However, this possibility is very unlikely, since
our 32Dcl3 cells appear to be already fully activated
and express high levels of L-selectin and Mac-1.
Furthermore, we have pre-incubated activated
mGEnC-1 with high concentrations of heparin in
order to compete off HS-bound chemokines. However,
this revealed that the adhesion of 32Dcl3 granulocyte
cells was not affected (data not shown) as has been
shown by others [16]. Other in vitro studies under flow
conditions with different vascular beds also showed
that the addition of heparinoids decreased the number
of rolling and firmly adhering leucocytes to activated
endothelium [21–23]. In a recent study, it was shown
that in particular endothelial HS is important for
the leucocyte trafficking over activated endothelium.
Mice that were conditionally deficient in the HS
biosynthetic enzyme N-deacetylase/N-sulfotransfer-
ase-1, i.e. in both endothelium and leucocytes,
showed a 2–3-fold reduction of N-, 2-O- and
6-O-sulfated groups on the endothelium and a higher
velocity of rolling leucocytes by reduced binding to
L-selectin [24].
Treatment of proliferative forms of glomerulo-
nephritis with immunosuppressive drugs like cortico-
steroids and cyclophosphamide is basically the same as
30 years ago. Therefore, the determination of the exact
structure of HS domains on activated glomerular
endothelium that serve as ligands for L-selectin,
Mac-1 or other leucocyte receptors could lead to the
development of well-defined HS-based therapeutics
without anticoagulant activity for supplementary
treatment of these forms of glomerulonephritis.
However, determination of the fine structure, i.e.
sequence, of these specific HS domains remains a
major future challenge, which will require additional
research, in which our glomerular endothelial cell
line mGEnC-1 and the flow system used could be of
value. Until these defined HS-based compounds
become available, it is an interesting option to evaluate
heparin and low molecular weight heparin prepara-
tions with a low antithrombotic activity as supplemen-
tary therapeutics in the treatment of proliferative
glomerulonephritis [25].
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